Development of a clinical practice guideline for weaning and discontinuing parenteral nutrition in hospitalized children as part of a CLABSI‐focused quality improvement initiative

Author(s):  
Amber V. Pulido ◽  
Kim Kellogg ◽  
Kathryn Hunt ◽  
Cheryl Davis
2016 ◽  
Vol 21 (1) ◽  
pp. 54-65 ◽  
Author(s):  
Rima Abdouni ◽  
Teri Reyburn-Orne ◽  
Tarek H. Youssef ◽  
Imad Y. Haddad ◽  
Richard D. Gerkin

OBJECTIVES: To determine whether utilization of a hospital-based clinical practice guideline for the care of pediatric iatrogenic opioid dependence (IOD) would promote a decrease in opioid exposure and improve management of opioid abstinence syndrome (AS). METHODS: This study is a retrospective chart review of critically ill patients from a tertiary care children's hospital. Inclusion criteria included mechanically ventilated patients up to 18 years of age who received continuous opioid infusions for at least 7 days and any length of methadone administration. Data on IOD patients from January 2005 to June 2010 was divided into 3 periods: baseline, phase 1, and phase 2. Primary outcome was decrease in opioid exposure, measured by methadone duration of use and any additional opioid bolus doses used in AS management. Documentation of additional opioid bolus doses was regarded as a surrogate measure of AS. Secondary outcomes included total cumulative fentanyl dose, continuous fentanyl infusion duration of use, and hospital and pediatric intensive care unit length of stay. RESULTS: There was a significant decrease in methadone duration of use in IOD patients from 15.3 ± 8.7 days at baseline to 9.5 ± 3.7 days during phase 1 (p = 0.002), to 8.1 ± 3.7 days on phase 2 (reduction not significant, p = 0.106) of this evaluation. Additional opioid bolus doses were significantly lower from baseline to phase 1 (5.5 ± 5.1 vs. 1.8 ± 2.3, p = 0.001) and from phase 1 to phase 2 (1.8 ± 2.3 vs. 0.2 ± 1.5, p = 0.003). For the remaining outcomes, differences were not observed among the evaluation periods, except for the total cumulative fentanyl dose, which was reduced from 2.8 ± 3.7 mg/kg at baseline to 1 ± 1 mg/kg only during phase 1 (p = 0.017). CONCLUSIONS: Introduction of a standardized, hospital-based clinical practice guideline for children with IOD reduced the length of exposure to opioids and improved opioid AS management.


Nutrition ◽  
2008 ◽  
Vol 24 (10) ◽  
pp. 998-1012 ◽  
Author(s):  
Lyn Gillanders ◽  
Katherina Angstmann ◽  
Patrick Ball ◽  
Christine Chapman-Kiddell ◽  
Gil Hardy ◽  
...  

2019 ◽  
Vol 160 (2) ◽  
pp. 206-212
Author(s):  
Sandra A. Finestone ◽  
Terri Giordano ◽  
Ron B. Mitchell ◽  
Sandra A. Walsh ◽  
Sarah S. O’Connor ◽  
...  

This plain language summary for patients serves as an overview explaining tonsillectomy in children and to help patients, caregivers, and clinicians in their discussions about the reasons that a tonsillectomy may be needed, management options, and care related to the procedure. This summary applies to patients ages 1 through 18 years and is based on the 2019 “Clinical Practice Guideline: Tonsillectomy in Children (Update).” This evidence-based guideline mainly addresses the need for tonsillectomy based on breathing problems that take place during sleep and repeated sore throats or “tonsillitis.” The guideline was developed to identify quality improvement opportunities in managing children under consideration for tonsillectomy and to create clear recommendations for clinicians to use in medical practice.


Sign in / Sign up

Export Citation Format

Share Document